Your browser doesn't support javascript.
loading
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction.
Zangari, Brendan; Tsuji, Takemasa; Matsuzaki, Junko; Mohammadpour, Hemn; Eppolito, Cheryl; Battaglia, Sebastiano; Ito, Fumito; Chodon, Thinle; Koya, Richard; Robert McGray, A J; Odunsi, Kunle.
Afiliación
  • Zangari B; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Tsuji T; University of Chicago Medicine Comprehensive Cancer Center, 5841 S Maryland Ave, Chicago, IL, 60637, USA.
  • Matsuzaki J; Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, USA.
  • Mohammadpour H; University of Chicago Medicine Comprehensive Cancer Center, 5841 S Maryland Ave, Chicago, IL, 60637, USA.
  • Eppolito C; Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, USA.
  • Battaglia S; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Ito F; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Chodon T; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Koya R; Department of Genetics and Genomics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Robert McGray AJ; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Odunsi K; University of Chicago Medicine Comprehensive Cancer Center, 5841 S Maryland Ave, Chicago, IL, 60637, USA.
Cancer Immunol Immunother ; 71(12): 2881-2898, 2022 Dec.
Article en En | MEDLINE | ID: mdl-35460379
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Factor 1 de Transcripción de Linfocitos T / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Factor 1 de Transcripción de Linfocitos T / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos